WebbFind real-time INCR - InterCure Ltd stock quotes, company profile, news and forecasts from CNN Business. INCR - InterCure Ltd Stock quote - CNNMoney.com Markets WebbNASDAQ: INCR TASE: INCR TSX: INCR.U InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing ...
InterCure Ltd (INCR) Stock Falls -10.31% This Week: Is It a Good …
WebbInterCure Ltd. (IL) started trading on July 2, 2024, operates in the Healthcare sector (Drug Manufacturers—Specialty & Generic industry), has 350 full-time employees, and is led by Mr. Alexander Rabinovitch. WebbIntercure Ltd. HSKA: Raising target price to $123.00 HESKA CORP has an Investment Rating of HOLD; a target price of $123.000000; an Industry Subrating of Medium; a Management Subrating of Medium ... how to spell orphan
InterCure Stock: Why This Israeli Marijuana Stock Gained 100% in ...
Webb12 apr. 2024 · A high-level overview of InterCure Ltd. (INCR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Webb3 apr. 2024 · NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company") announced today that it has rescheduled its previously announced conference call to discuss the company's financial results for the full year … WebbLegal Name InterCure Ltd. Stock Symbol TLV:INCR. Company Type For Profit. Contact Email [email protected]. Phone Number 201-720-7750. InterCure is a medical device company that has developed and patented a technology platform for respiratory-based treatment of cardiovascular and pulmonary diseases. The Company has incorporated its … rds free tier